Source:
Hindustan
Subject: Science and Technology (Health Innovation), Indian Economy (Startups and Atmanirbhar Bharat)
Key points for Prelims: AIIMS New Delhi, Centre for Medical Innovation and Entrepreneurship (CMIE), Atmanirbhar Bharat, Startup India, Make in India, Bioincubator
Mains syllabus mapping
- General Studies Paper 2: Governance: institutional autonomy, conflict of interest in public institutions, public health delivery
- General Studies Paper 3: Science and Technology: indigenous technology, commercialisation of research, Startup ecosystem; Indian Economy: Atmanirbhar Bharat, Make in India, Startup India
Key facts for one-day exams
- AIIMS New Delhi issued the Faculty Entrepreneurship Policy.
- Eligible regular faculty must complete at least two years of service.
- The policy provides AIIMS with a non-dilutable 5% stake in faculty startups.
- Faculty startup activities are capped at 20% of working time.
- The Centre for Medical Innovation and Entrepreneurship is the AIIMS bioincubator.
AIIMS Faculty Entrepreneurship Policy: why in the news?
AIIMS Delhi has formally issued its Faculty Entrepreneurship Policy, enabling doctors and scientists to commercialise their research through startups, with a non-dilutable 5% institutional stake and a 20% work-time limit.
The All India Institute of Medical Sciences (AIIMS), New Delhi, has issued a Faculty Entrepreneurship Policy that allows its doctors and scientists to start their own startups or join existing ones. The policy aims to move medical research beyond laboratories and academic papers into practical patient-care applications, promoting indigenous technology for diagnosis and treatment.
Regular faculty members who have completed at least two years of service can participate as founders, promoters, directors, shareholders, advisers or mentors. However, patient care, teaching and research remain their primary responsibility, and they can devote a maximum of 20 percent of their working time to startup-related activities. For additional time, faculty must obtain institutional permission and take leave without pay.
Under the policy, AIIMS will hold a 5 percent stake in faculty-led startups, and this stake is protected from dilution when new investors enter or shares increase. Startups that use AIIMS technology or intellectual property must obtain licences and necessary approvals from the institute. Faculty shareholders can be associated with up to five startups, with their combined shareholding across all of them capped at 25 percent. The policy also requires that products developed by these startups be made available free or at concessional rates to patients treated at AIIMS.
The institute has already set up a bioincubator called the Centre for Medical Innovation and Entrepreneurship (CMIE) to provide technical advice, laboratory facilities and modern equipment. The policy states that the step has been taken keeping in view the government's Atmanirbhar Bharat, Make in India and Startup India initiatives.
What is the Startup India initiative?
The Startup India initiative was launched on 16 January 2016. The Department for Promotion of Industry and Internal Trade (DPIIT) is the nodal department for the Startup India initiative.
What does the policy allow and restrict?
Faculty can serve as founders, promoters, directors, shareholders, advisers or mentors in startups. Their clinical, teaching and research duties take precedence, and startup work is capped at 20% of working time. Faculty seeking more time must take leave without pay with institutional permission. A faculty shareholder can be associated with up to five startups, and the combined shareholding across them cannot exceed 25%.
How will AIIMS benefit and what safeguards exist?
AIIMS will hold a 5% stake in each faculty startup, protected against dilution when new investors enter or shares increase. Startups using AIIMS technology or intellectual property must obtain licences and approvals. Products must be made available free or at concessional rates to AIIMS patients, linking commercialisation with healthcare access. The policy is expected to help develop indigenous medical devices and treatment technologies.
Key terms
- Startup:
- A startup is a business venture established to develop and offer a product, service or business model.
- Intellectual property:
- Intellectual property refers to creations of the mind that may receive legal protection, such as inventions and literary works.
- Equity dilution:
- Equity dilution is a reduction in an existing owner's percentage shareholding when additional shares are issued.
- Business incubator:
- A business incubator supports early-stage ventures through resources such as mentoring, facilities and technical advice.
AIIMS Faculty Entrepreneurship Policy: why it matters for exams
Syllabus: Science and Technology: Medical innovation and biotechnology; Governance: Public institutions and healthcare delivery
Common mistake: Examiners may present the 5% AIIMS stake as the faculty shareholding ceiling; AIIMS has the 5% stake, while faculty members' combined shareholding across their startups is capped at 25%.
Mains practice questions
Question 1(GS-3 | 250 words | 15 marks)
Critically examine the proposal to allow AIIMS doctors and scientists to launch and hold stakes in startups, and suggest safeguards needed to balance innovation with patient care and public interest.
Answer outline
- Introduction: Open by noting that AIIMS New Delhi's Faculty Entrepreneurship Policy aims to move medical research from laboratories and papers into patient-care products, reflecting the push for indigenous health technology under Atmanirbhar Bharat and Startup India.
- Body:
- Benefits: commercialisation of research, indigenous diagnostic and treatment technology, retention of talented clinicians, and alignment with Make in India and Startup India.
- Risks of conflict of interest: faculty may divert time and attention from patient care, teaching and research, which remain their primary duties.
- Safeguards built into the policy: 20% working-time ceiling, two-year minimum service, leave without pay for extra time, the 5% non-dilutable institutional stake, and the cap on faculty shareholding at 25% across up to five startups.
- Equity and access concerns: the requirement that products be offered free or at concessional rates to AIIMS patients protects public interest, but enforcement and pricing for wider markets need scrutiny.
- Need for transparent licensing, independent oversight, and conflict-of-interest disclosure for IP use and procurement decisions within the institute.
- Conclusion: A balanced way forward keeps the incentives of entrepreneurship while strengthening monitoring, disclosure and patient-first norms, so that public medical institutions innovate without compromising their core mandate.
Question 2(GS-3 | 150 words | 10 marks)
Discuss how the Centre for Medical Innovation and Entrepreneurship (CMIE) bioincubator can strengthen India's medical technology ecosystem, and identify the constraints that such in-house incubators face.
Answer outline
- Introduction: Introduce the CMIE, set up by AIIMS New Delhi to provide technical advice, laboratory facilities and modern equipment to faculty-led ventures, as a model for converting clinical research into products.
- Body:
- Strengths: access to clinical expertise, lab infrastructure and equipment that early-stage founders often lack, reducing the cost of innovation.
- Link to national missions: supports Atmanirbhar Bharat and Startup India by promoting indigenous medical devices and diagnostics.
- Constraints: dependence on institutional approvals and licensing, limited commercial and regulatory expertise, and possible bureaucratic delays.
- Need for linkages with industry, venture capital and other institutions such as IITs to widen the innovation pipeline.
- Conclusion: With clear governance, commercial mentorship and inter-institutional collaboration, CMIE-type incubators can become effective engines of indigenous medical innovation.
Stuck? Get it in one tap
AIIMS New Delhi allows eligible faculty to start or join businesses based on medical innovations. The institute retains a 5% ownership stake that will not be reduced by additional shares. Faculty must prioritise patient care, teaching and research, and need approval to use institutional technology or intellectual property.
- Science and Technology: Medical innovation and biotechnology
- Governance: Public institutions and healthcare delivery
Related concepts: Startup, Intellectual property, Equity dilution, Business incubator
Practice questions
Pick an answer, then read the explanation.
- Q1Easy
Which institution established the Centre for Medical Innovation and Entrepreneurship as a bioincubator?
Explanation: AIIMS New Delhi established the Centre for Medical Innovation and Entrepreneurship as its bioincubator. The centre supports medical startups with technical advice, laboratories and equipment.
- Q2Hard
Consider the following statements about the AIIMS New Delhi Faculty Entrepreneurship Policy:
- 1.Eligible regular faculty must have completed at least two years of service.
- 2.The institutional stake is reduced when new investors enter the startup.
- 3.A faculty shareholder may be associated with up to five startups.
Which of the statements given above is/are correct?
Explanation: Statements 1 and 3 are correct: the policy requires two years of regular service and permits a faculty shareholder to join up to five startups. Statement 2 is incorrect because the 5% AIIMS stake is protected against dilution.
- Q3Medium
What is the maximum share of working time that AIIMS New Delhi faculty can devote to startup activities under the Faculty Entrepreneurship Policy without taking additional leave?
Explanation: The policy caps startup activities at 20% of working time. Additional time requires institutional permission and leave without pay.
- Q4Medium
What is the principal objective of the AIIMS New Delhi Faculty Entrepreneurship Policy?
Explanation: The policy supports the practical use of medical research through indigenous devices and treatment technologies. Clinical, teaching and research duties remain priorities, while use of AIIMS intellectual property requires licensing and approvals.
Frequently asked questions
1. Who can participate in the AIIMS Delhi Faculty Entrepreneurship Policy?
Regular faculty members who have completed at least two years of service can participate.
2. What stake will AIIMS Delhi hold in faculty startups?
AIIMS will hold a 5% stake protected against dilution when new investors enter or shares increase.
3. How much working time can AIIMS faculty spend on startups?
Faculty can devote up to 20% of working time to startup activities. Additional time requires permission and leave without pay.
4. What support does the AIIMS Delhi bioincubator provide?
The Centre for Medical Innovation and Entrepreneurship provides technical advice, laboratory facilities and modern equipment.
All sources
Original16 November 2026 · Read story
